1282516-69-1,MFCD15475002
Catalog No.:AA000XTK

1282516-69-1 | 9-Bromo-2-iodo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$142.00   $99.00
- +
250mg
95%
in stock  
$190.00   $133.00
- +
500mg
95%
in stock  
$317.00   $222.00
- +
1g
95%
in stock  
$476.00   $333.00
- +
5g
95%
in stock  
$1,498.00   $1,048.00
- +
10g
95%
in stock  
$2,524.00   $1,767.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA000XTK
Chemical Name:
9-Bromo-2-iodo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
CAS Number:
1282516-69-1
Molecular Formula:
C11H8BrIN2O
Molecular Weight:
391.0025
MDL Number:
MFCD15475002
SMILES:
Brc1ccc2c(c1)OCCn1c2nc(c1)I
Properties

Downstream Synthesis Route

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2012/245144,2012,A1

[2]Ndubaku,ChudiO.;Heffron,TimothyP.;Staben,StevenT.;Baumgardner,Matthew;Blaquiere,Nicole;Bradley,Erin;Bull,Richard;Do,Steven;Dotson,Jennafer;Dudley,Danette;Edgar,KyleA.;Friedman,LoriS.;Goldsmith,Richard;Heald,RobertA.;Kolesnikov,Aleksandr;Lee,Leslie;Lewis,Cristina;Nannini,Michelle;Nonomiya,Jim;Pang,Jodie;Price,Steve;Prior,WeiWei;Salphati,Laurent;Sideris,Steve;Wallin,JefferyJ.;Wang,Lan;Wei,Binqing;Sampath,Deepak;Olivero,AlanG.[JournalofMedicinalChemistry,2013,vol.56,#11,p.4597-4610]

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/1645,2017,A1

[4]CurrentPatentAssignee:ROCHEHOLDINGAG-US2017/2022,2017,A1

[5]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2018/109204,2018,A1

[6]Han;Kelly,SeanM.;Cravillion,Theresa;Savage,ScottJ.;Nguyen,Tina;Gosselin,Francis[Tetrahedron,2019,vol.75,#32,p.4351-4357]

[7]Remarchuk,Travis;Angelaud,Rémy;Askin,David;Kumar,Archana;Thompson,AndrewS.;Cheng,Hua;Reichwein,JohnF.;Chen,Yanping;St-Jean,Frédéric[OrganicProcessResearchandDevelopment,2019,vol.23,#5,p.775-782]

[8]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-EP3805231,2021,A1

[9]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-CN112830935,2021,A

[1]Ndubaku,ChudiO.;Heffron,TimothyP.;Staben,StevenT.;Baumgardner,Matthew;Blaquiere,Nicole;Bradley,Erin;Bull,Richard;Do,Steven;Dotson,Jennafer;Dudley,Danette;Edgar,KyleA.;Friedman,LoriS.;Goldsmith,Richard;Heald,RobertA.;Kolesnikov,Aleksandr;Lee,Leslie;Lewis,Cristina;Nannini,Michelle;Nonomiya,Jim;Pang,Jodie;Price,Steve;Prior,WeiWei;Salphati,Laurent;Sideris,Steve;Wallin,JefferyJ.;Wang,Lan;Wei,Binqing;Sampath,Deepak;Olivero,AlanG.[JournalofMedicinalChemistry,2013,vol.56,#11,p.4597-4610]

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/1645,2017,A1

[2]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2018/109204,2018,A1

[3]Han;Kelly,SeanM.;Cravillion,Theresa;Savage,ScottJ.;Nguyen,Tina;Gosselin,Francis[Tetrahedron,2019,vol.75,#32,p.4351-4357]

[4]Han;Kelly,SeanM.;Cravillion,Theresa;Savage,ScottJ.;Nguyen,Tina;Gosselin,Francis[Tetrahedron,2019,vol.75,#32,p.4351-4357]

[5]Han;Kelly,SeanM.;Cravillion,Theresa;Savage,ScottJ.;Nguyen,Tina;Gosselin,Francis[Tetrahedron,2019,vol.75,#32,p.4351-4357]

[6]Han;Kelly,SeanM.;Cravillion,Theresa;Savage,ScottJ.;Nguyen,Tina;Gosselin,Francis[Tetrahedron,2019,vol.75,#32,p.4351-4357]

[7]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2022/251567,2022,A1

1282516-69-1    4042-43-7   
(R)-3-(9-bromo-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-4-methyloxazolidin-2-one 

[1]Patent:WO2017/1645,2017,A1.Locationinpatent:Page/Pagecolumn79;80

1282516-69-1    4042-43-7   
(R)-3-(9-bromo-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-4-methyloxazolidin-2-one 
 
(R)-3-(9-iodo-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-4-methyloxazolidin-2-one 

[1]Patent:WO2017/1645,2017,A1.Locationinpatent:Page/Pagecolumn79

[2]Patent:US2017/2022,2017,A1.Locationinpatent:Paragraph0187-0190

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Building Blocks
More >
Tags:1282516-69-1 Molecular Formula|1282516-69-1 MDL|1282516-69-1 SMILES|1282516-69-1 9-Bromo-2-iodo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
Catalog No.: AA000XTK
1282516-69-1,MFCD15475002
1282516-69-1 | 9-Bromo-2-iodo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
Pack Size: 100mg
Purity: 95%
in stock
$142.00 $99.00
Pack Size: 250mg
Purity: 95%
in stock
$190.00 $133.00
Pack Size: 500mg
Purity: 95%
in stock
$317.00 $222.00
Pack Size: 1g
Purity: 95%
in stock
$476.00 $333.00
Pack Size: 5g
Purity: 95%
in stock
$1,498.00 $1,048.00
Pack Size: 10g
Purity: 95%
in stock
$2,524.00 $1,767.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA000XTK
Chemical Name: 9-Bromo-2-iodo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
CAS Number: 1282516-69-1
Molecular Formula: C11H8BrIN2O
Molecular Weight: 391.0025
MDL Number: MFCD15475002
SMILES: Brc1ccc2c(c1)OCCn1c2nc(c1)I
Properties
Downstream Synthesis Route
1282516-67-9    1282516-69-1 

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2012/245144,2012,A1

[2]Ndubaku,ChudiO.;Heffron,TimothyP.;Staben,StevenT.;Baumgardner,Matthew;Blaquiere,Nicole;Bradley,Erin;Bull,Richard;Do,Steven;Dotson,Jennafer;Dudley,Danette;Edgar,KyleA.;Friedman,LoriS.;Goldsmith,Richard;Heald,RobertA.;Kolesnikov,Aleksandr;Lee,Leslie;Lewis,Cristina;Nannini,Michelle;Nonomiya,Jim;Pang,Jodie;Price,Steve;Prior,WeiWei;Salphati,Laurent;Sideris,Steve;Wallin,JefferyJ.;Wang,Lan;Wei,Binqing;Sampath,Deepak;Olivero,AlanG.[JournalofMedicinalChemistry,2013,vol.56,#11,p.4597-4610]

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/1645,2017,A1

[4]CurrentPatentAssignee:ROCHEHOLDINGAG-US2017/2022,2017,A1

[5]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2018/109204,2018,A1

[6]Han;Kelly,SeanM.;Cravillion,Theresa;Savage,ScottJ.;Nguyen,Tina;Gosselin,Francis[Tetrahedron,2019,vol.75,#32,p.4351-4357]

[7]Remarchuk,Travis;Angelaud,Rémy;Askin,David;Kumar,Archana;Thompson,AndrewS.;Cheng,Hua;Reichwein,JohnF.;Chen,Yanping;St-Jean,Frédéric[OrganicProcessResearchandDevelopment,2019,vol.23,#5,p.775-782]

[8]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-EP3805231,2021,A1

[9]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-CN112830935,2021,A

1282516-69-1    1282512-48-4 

[1]Ndubaku,ChudiO.;Heffron,TimothyP.;Staben,StevenT.;Baumgardner,Matthew;Blaquiere,Nicole;Bradley,Erin;Bull,Richard;Do,Steven;Dotson,Jennafer;Dudley,Danette;Edgar,KyleA.;Friedman,LoriS.;Goldsmith,Richard;Heald,RobertA.;Kolesnikov,Aleksandr;Lee,Leslie;Lewis,Cristina;Nannini,Michelle;Nonomiya,Jim;Pang,Jodie;Price,Steve;Prior,WeiWei;Salphati,Laurent;Sideris,Steve;Wallin,JefferyJ.;Wang,Lan;Wei,Binqing;Sampath,Deepak;Olivero,AlanG.[JournalofMedicinalChemistry,2013,vol.56,#11,p.4597-4610]

1282516-69-1    2060571-02-8 

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/1645,2017,A1

[2]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2018/109204,2018,A1

[3]Han;Kelly,SeanM.;Cravillion,Theresa;Savage,ScottJ.;Nguyen,Tina;Gosselin,Francis[Tetrahedron,2019,vol.75,#32,p.4351-4357]

[4]Han;Kelly,SeanM.;Cravillion,Theresa;Savage,ScottJ.;Nguyen,Tina;Gosselin,Francis[Tetrahedron,2019,vol.75,#32,p.4351-4357]

[5]Han;Kelly,SeanM.;Cravillion,Theresa;Savage,ScottJ.;Nguyen,Tina;Gosselin,Francis[Tetrahedron,2019,vol.75,#32,p.4351-4357]

[6]Han;Kelly,SeanM.;Cravillion,Theresa;Savage,ScottJ.;Nguyen,Tina;Gosselin,Francis[Tetrahedron,2019,vol.75,#32,p.4351-4357]

[7]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2022/251567,2022,A1

1282516-69-1    4042-43-7   
(R)-3-(9-bromo-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-4-methyloxazolidin-2-one 

[1]Patent:WO2017/1645,2017,A1.Locationinpatent:Page/Pagecolumn79;80

1282516-69-1    4042-43-7   
(R)-3-(9-bromo-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-4-methyloxazolidin-2-one 
 
(R)-3-(9-iodo-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-4-methyloxazolidin-2-one 

[1]Patent:WO2017/1645,2017,A1.Locationinpatent:Page/Pagecolumn79

[2]Patent:US2017/2022,2017,A1.Locationinpatent:Paragraph0187-0190

Building Blocks More >
Submit
© 2017 AA BLOCKS, INC. All rights reserved.